The correlation between chronic inflammation and cancer has been supported by epidemiological and experimental studies on humans and animal models [13,15,17] along with the observation that preventive treatments with anti-inflammatory drugs such as aspirin or cyclooxygenase-2 (COX-2) inhibitors reduce the risk of developing colorectal and breast cancer and even mortality [15,18,19]. Here, PTGS2 is linked to breast cancer.